Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Blog
Biosimilars Council Press Releases
Blog
Blog
June 17, 2020
AAM
How “Stocking the Pantry” Protects the Supply Chain
Blog
June 16, 2020
Founders Series
Thank you, Agnes Varis
Blog
June 4, 2020
AAM
Strengthening the U.S. Pharmaceutical Supply Chain: What We Know—and What We Don’t
Blog
May 13, 2020
Founders Series
Thank You, Bill Haddad
Blog
May 13, 2020
AAM
AAM Supports Updating Medicare to Lower Costs for America’s Seniors
Blog
March 30, 2020
AAM
COVID-19: This Week’s Initiatives From the Generic and Biosimilars Industry
Blog
March 19, 2020
AAM
AAM’s COVID-19 Response: Helping Patients and Families Meet Their Health Care Needs
Blog
February 28, 2020
AAM
AAM Interim CEO Jeff Francer on COVID-19
Blog
February 28, 2020
AAM
Stories and Data: How AAM Equips Advocates in the States
Blog
February 27, 2020
AAM
The First (Price) Cut Is the Steepest
Blog
February 25, 2020
AAM
Savings by Condition: The Latest Data
Blog
January 9, 2020
AAM
Competition Matters. That’s Why We Need to Further Improve IPR.
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
